The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Bioactive Protein and Peptides Market Research Report 2025

Global Bioactive Protein and Peptides Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1598116

No of Pages : 93

Ask Your Query

Synopsis

Bioactive proteins and peptides are considered as important ingredients in functional foods, nutraceuticals and personal care. The roles of bioactive proteins and peptides include antioxidant, antimicrobial, antihypertensive, immunomodulatory and other biological activities.

The global Bioactive Protein and Peptides market was valued at US$ 1695.8 million in 2023 and is anticipated to reach US$ 2706.1 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.

Global key players of bioactive protein and peptides include Gelita, Kerry Group, Vital Proteins, Rousselot, BRF Ingredients, etc. The top five players hold a share over 50%. North America is the largest market, has a share about 40%, followed by Europe, and Asia-Pacific, with share 30% and 20%, separately.

This report aims to provide a comprehensive presentation of the global market for Bioactive Protein and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bioactive Protein and Peptides.

Report Scope

The Bioactive Protein and Peptides market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bioactive Protein and Peptides market comprehensively. Regional market sizes, concerning products by Source, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bioactive Protein and Peptides companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Source, by Application, and by regions.

Market Segmentation

By Company

  • Gelita
  • Kerry Group
  • Vital Proteins
  • Rousselot
  • BRF Ingredients
  • Bunge Ltd
  • Ingredia Nutritional
  • Gelatines Weishardt
  • PanTheryx
  • Hubei Reborn Biotech
  • Seagarden
  • Shandong Hengxin Biotech
  • Baotou Dongbao Bio-Tech
  • Wuhan Jiushengtang Biotech
  • Morinaga Milk
  • Collagile
  • Nuritas
  • SmartPEP

Segment by Source

  • Plant Source
  • Animal Source

Segment by Application

  • Functional Food
  • Dietary Supplements
  • Personal Care
  • Animal Nutrition
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Source, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bioactive Protein and Peptides companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Source
1.2.1 Global Bioactive Protein and Peptides Market Size Growth Rate by Source: 2019 VS 2023 VS 2030
1.2.2 Plant Source
1.2.3 Animal Source
1.3 Market by Application
1.3.1 Global Bioactive Protein and Peptides Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Functional Food
1.3.3 Dietary Supplements
1.3.4 Personal Care
1.3.5 Animal Nutrition
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Bioactive Protein and Peptides Market Perspective (2019-2030)
2.2 Bioactive Protein and Peptides Growth Trends by Region
2.2.1 Global Bioactive Protein and Peptides Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Bioactive Protein and Peptides Historic Market Size by Region (2019-2024)
2.2.3 Bioactive Protein and Peptides Forecasted Market Size by Region (2025-2030)
2.3 Bioactive Protein and Peptides Market Dynamics
2.3.1 Bioactive Protein and Peptides Industry Trends
2.3.2 Bioactive Protein and Peptides Market Drivers
2.3.3 Bioactive Protein and Peptides Market Challenges
2.3.4 Bioactive Protein and Peptides Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bioactive Protein and Peptides Players by Revenue
3.1.1 Global Top Bioactive Protein and Peptides Players by Revenue (2019-2024)
3.1.2 Global Bioactive Protein and Peptides Revenue Market Share by Players (2019-2024)
3.2 Global Bioactive Protein and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Bioactive Protein and Peptides Revenue
3.4 Global Bioactive Protein and Peptides Market Concentration Ratio
3.4.1 Global Bioactive Protein and Peptides Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bioactive Protein and Peptides Revenue in 2023
3.5 Bioactive Protein and Peptides Key Players Head office and Area Served
3.6 Key Players Bioactive Protein and Peptides Product Solution and Service
3.7 Date of Enter into Bioactive Protein and Peptides Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bioactive Protein and Peptides Breakdown Data by Source
4.1 Global Bioactive Protein and Peptides Historic Market Size by Source (2019-2024)
4.2 Global Bioactive Protein and Peptides Forecasted Market Size by Source (2025-2030)
5 Bioactive Protein and Peptides Breakdown Data by Application
5.1 Global Bioactive Protein and Peptides Historic Market Size by Application (2019-2024)
5.2 Global Bioactive Protein and Peptides Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Bioactive Protein and Peptides Market Size (2019-2030)
6.2 North America Bioactive Protein and Peptides Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Bioactive Protein and Peptides Market Size by Country (2019-2024)
6.4 North America Bioactive Protein and Peptides Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Bioactive Protein and Peptides Market Size (2019-2030)
7.2 Europe Bioactive Protein and Peptides Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Bioactive Protein and Peptides Market Size by Country (2019-2024)
7.4 Europe Bioactive Protein and Peptides Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Bioactive Protein and Peptides Market Size (2019-2030)
8.2 Asia-Pacific Bioactive Protein and Peptides Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2019-2024)
8.4 Asia-Pacific Bioactive Protein and Peptides Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Bioactive Protein and Peptides Market Size (2019-2030)
9.2 Latin America Bioactive Protein and Peptides Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Bioactive Protein and Peptides Market Size by Country (2019-2024)
9.4 Latin America Bioactive Protein and Peptides Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Bioactive Protein and Peptides Market Size (2019-2030)
10.2 Middle East & Africa Bioactive Protein and Peptides Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2019-2024)
10.4 Middle East & Africa Bioactive Protein and Peptides Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Gelita
11.1.1 Gelita Company Detail
11.1.2 Gelita Business Overview
11.1.3 Gelita Bioactive Protein and Peptides Introduction
11.1.4 Gelita Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.1.5 Gelita Recent Development
11.2 Kerry Group
11.2.1 Kerry Group Company Detail
11.2.2 Kerry Group Business Overview
11.2.3 Kerry Group Bioactive Protein and Peptides Introduction
11.2.4 Kerry Group Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.2.5 Kerry Group Recent Development
11.3 Vital Proteins
11.3.1 Vital Proteins Company Detail
11.3.2 Vital Proteins Business Overview
11.3.3 Vital Proteins Bioactive Protein and Peptides Introduction
11.3.4 Vital Proteins Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.3.5 Vital Proteins Recent Development
11.4 Rousselot
11.4.1 Rousselot Company Detail
11.4.2 Rousselot Business Overview
11.4.3 Rousselot Bioactive Protein and Peptides Introduction
11.4.4 Rousselot Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.4.5 Rousselot Recent Development
11.5 BRF Ingredients
11.5.1 BRF Ingredients Company Detail
11.5.2 BRF Ingredients Business Overview
11.5.3 BRF Ingredients Bioactive Protein and Peptides Introduction
11.5.4 BRF Ingredients Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.5.5 BRF Ingredients Recent Development
11.6 Bunge Ltd
11.6.1 Bunge Ltd Company Detail
11.6.2 Bunge Ltd Business Overview
11.6.3 Bunge Ltd Bioactive Protein and Peptides Introduction
11.6.4 Bunge Ltd Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.6.5 Bunge Ltd Recent Development
11.7 Ingredia Nutritional
11.7.1 Ingredia Nutritional Company Detail
11.7.2 Ingredia Nutritional Business Overview
11.7.3 Ingredia Nutritional Bioactive Protein and Peptides Introduction
11.7.4 Ingredia Nutritional Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.7.5 Ingredia Nutritional Recent Development
11.8 Gelatines Weishardt
11.8.1 Gelatines Weishardt Company Detail
11.8.2 Gelatines Weishardt Business Overview
11.8.3 Gelatines Weishardt Bioactive Protein and Peptides Introduction
11.8.4 Gelatines Weishardt Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.8.5 Gelatines Weishardt Recent Development
11.9 PanTheryx
11.9.1 PanTheryx Company Detail
11.9.2 PanTheryx Business Overview
11.9.3 PanTheryx Bioactive Protein and Peptides Introduction
11.9.4 PanTheryx Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.9.5 PanTheryx Recent Development
11.10 Hubei Reborn Biotech
11.10.1 Hubei Reborn Biotech Company Detail
11.10.2 Hubei Reborn Biotech Business Overview
11.10.3 Hubei Reborn Biotech Bioactive Protein and Peptides Introduction
11.10.4 Hubei Reborn Biotech Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.10.5 Hubei Reborn Biotech Recent Development
11.11 Seagarden
11.11.1 Seagarden Company Detail
11.11.2 Seagarden Business Overview
11.11.3 Seagarden Bioactive Protein and Peptides Introduction
11.11.4 Seagarden Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.11.5 Seagarden Recent Development
11.12 Shandong Hengxin Biotech
11.12.1 Shandong Hengxin Biotech Company Detail
11.12.2 Shandong Hengxin Biotech Business Overview
11.12.3 Shandong Hengxin Biotech Bioactive Protein and Peptides Introduction
11.12.4 Shandong Hengxin Biotech Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.12.5 Shandong Hengxin Biotech Recent Development
11.13 Baotou Dongbao Bio-Tech
11.13.1 Baotou Dongbao Bio-Tech Company Detail
11.13.2 Baotou Dongbao Bio-Tech Business Overview
11.13.3 Baotou Dongbao Bio-Tech Bioactive Protein and Peptides Introduction
11.13.4 Baotou Dongbao Bio-Tech Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.13.5 Baotou Dongbao Bio-Tech Recent Development
11.14 Wuhan Jiushengtang Biotech
11.14.1 Wuhan Jiushengtang Biotech Company Detail
11.14.2 Wuhan Jiushengtang Biotech Business Overview
11.14.3 Wuhan Jiushengtang Biotech Bioactive Protein and Peptides Introduction
11.14.4 Wuhan Jiushengtang Biotech Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.14.5 Wuhan Jiushengtang Biotech Recent Development
11.15 Morinaga Milk
11.15.1 Morinaga Milk Company Detail
11.15.2 Morinaga Milk Business Overview
11.15.3 Morinaga Milk Bioactive Protein and Peptides Introduction
11.15.4 Morinaga Milk Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.15.5 Morinaga Milk Recent Development
11.16 Collagile
11.16.1 Collagile Company Detail
11.16.2 Collagile Business Overview
11.16.3 Collagile Bioactive Protein and Peptides Introduction
11.16.4 Collagile Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.16.5 Collagile Recent Development
11.17 Nuritas
11.17.1 Nuritas Company Detail
11.17.2 Nuritas Business Overview
11.17.3 Nuritas Bioactive Protein and Peptides Introduction
11.17.4 Nuritas Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.17.5 Nuritas Recent Development
11.18 SmartPEP
11.18.1 SmartPEP Company Detail
11.18.2 SmartPEP Business Overview
11.18.3 SmartPEP Bioactive Protein and Peptides Introduction
11.18.4 SmartPEP Revenue in Bioactive Protein and Peptides Business (2019-2024)
11.18.5 SmartPEP Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock